1. Home
  2. /Live Rates
  3. /PFE/USD
PFE Pfizer
TYPE Stocks
GROUP Stocks
BASE Pfizer
SECOND US Dollar
<% (signals.list.current.rate).substr(0,7) %>
<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)
MARKETS TREND
OPEN
<% (signals.list.current.openrate).substr(0,9) %>
HIGH
<% (signals.list.current.high).substr(0,9) %>
LOW
<% (signals.list.current.low).substr(0,9) %>
START TRADING
START TRADING
Multi Charts
  • Basic Chart
  • Technical Chart
PFE/USD NEWS
All News
<% article.title| cut:true:60:' ...' %>
<% article.time_ago %> ago
PFE/USD Signals
DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM
ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM
<% signal.pair %> (<% signal.rate %>) <% signal.action %>
<% signal.status %>
Long Term
Entry Price
Stop Loss
Take Profit
PREMIUM ONLY
<% signal.stopLoss %> N/A
PREMIUM ONLY
<% signal.takeProfit %> N/A
PREMIUM ONLY
GO PREMIUM
TRADE NOW
GET READY

Read More
<% signal.comment %>
Description
<% signal.description %>
LATEST ANALYSIS
<% item.time_ago %> Ago
<% item.title %>
<% item.deltaTime %>
Full Analysis Feed

Last Updated: Feb 26, 2025 08:13:29 AM (GMT)

PFE/USD: The current market price is $26.43, reflecting a 0.38% increase from the previous close. Today's high-impact economic events, such as the New Home Sales (expected to drop to 0.68 from 0.698) and the MoM figure (consensus -2.6 from 3.6), may influence market sentiment.Support and Resistance Levels Key support levels are at $25.52, $25.55, and $25.60, while resistance levels stand at $26.07, $26.09, and $26.12. The pivot point is identified at $25.85.Indicators The RSI is at 57.43, suggesting a neutral market. The ADX shows strength with a value of 47.73, indicating a strong trend. The ATR is $0.24, reflecting moderate volatility, while the Parabolic SAR is at $25.93, suggesting bullish momentum. The 50-day SMA and 200-day EMA confirm a positive trend given their recent upward movements.Market Sentiment Since the market price is above the pivot point ($25.85) and indicators support a bullish trend, a continuation of upward momentum is likely.

Pfizer Stock Info

Pfizer Inc. (PFE) is a multinational pharmaceutical corporation that specializes in developing and manufacturing drugs and vaccines. In this article, we'll take a closer look at Pfizer's stock performance and provide a forecast of the company's future stock price movements.

Pfizer Stock Price Forecast

A forecast of Pfizer's stock price reveals that the company's stock is expected to continue to perform well over the coming years. The PFE USD price has been on an uptrend for the past several years, hitting an all-time high of over $50 in early 2022. While the stock has experienced some volatility in recent months, it has held relatively steady at around $45 as of April 2023.

Analysts forecast that Pfizer's stock will continue to perform well in the future, with an average annual growth rate of around 7%. This growth is largely driven by Pfizer's strong pipeline of drugs and vaccines, including its COVID-19 vaccine, which has been a significant contributor to the company's recent revenue growth.

Pfizer Share Price Forecast

A more detailed share price forecast for Pfizer's stock reveals that the company is trading above its 50-day and 200-day moving averages, indicating a bullish trend. The stock has also formed a symmetrical triangle pattern, which is a neutral technical indicator that suggests a potential breakout in the future.

Investors should watch for a breakout from this pattern as a potential signal for a bullish or bearish trend to resume. Additionally, investors should monitor any updates regarding Pfizer's drug and vaccine pipeline, as positive developments could further drive the stock's growth.

Pfizer Forecast

A forecast of Pfizer's future performance suggests that the company is well-positioned for continued growth in the pharmaceutical industry. The company's strong pipeline of drugs and vaccines, including its COVID-19 vaccine, is expected to drive revenue growth in the coming years.

Pfizer's recent acquisition of Array BioPharma, a biotech company specializing in cancer drugs, is also expected to bolster the company's drug development capabilities and contribute to its future growth.

Pfizer Stock Price Forecast

Fundamental analysis of Pfizer's stock reveals that the company has a strong financial position, with high revenue growth and strong profitability. In the most recent quarter, Pfizer reported revenue growth of over 70%, driven by strong performance in its BioNTech alliance and oncology portfolio.

Overall, Pfizer's stock price forecast suggests that the company is in a strong position for continued growth in the pharmaceutical industry, with a focus on developing new drugs and vaccines to address unmet medical needs. Investors who are interested in investing in Pfizer's stock should conduct their own due diligence and consult with a financial advisor before making any investment decisions.

Add 3442

Add 3440